Nureca Share Price: Find the latest news on Nureca Stock Price. Get all the information on Nureca with historic price charts for NSE / BSE. Experts & Broker view also get the Nureca Ltd. buy/sell tips detailed news, announcements, Forecasts, Analysts, Valuation, Earning forecasts, Estimates, Recommendations, Analysts Ratings, financial report, company information, annual report, balance sheet, profit & loss account, results and more.
Explore Now
New Delhi: The second wave of Covid-19 cases in India has badly hit investor sentiment on Dalal Street. However, a recent debutant has defied gravity and delivered up to 150 per cent return over issue price in just one-and-a-half months.
The stock is Nureca, a healthcare and wellness products distributor company, which got listed at Rs 634.95 at a 58.74 per cent premium to its issue price of Rs 400 on February 25, 2021. The stock has surged to trade at Rs 951 on Friday, April 16.
Nureca is a leading player of products that are in high demand due to Coronavirus. The second wave of the pandemic has increased demand for products like oximeters, thermometers, BP monitors, nebulisers and multivitamins, say analysts and market watchers.
Shares of the recently-listed healthcare supplies company Nureca rallied 10 per cent and hit a new high of Rs 929 on the BSE on Monday in an otherwise weak market. At 01:48 pm, it was trading 7 per cent higher at Rs 906, against 3.5 per cent decline in the S&P BSE Sensex.
In the past three days, the stock of the home healthcare and wellness products provider has jumped 36 per cent and soared 132 per cent against its issue price of Rs 400 per share. Nureca’s Rs 100-crore IPO had seen more than 40 times oversubscription.
As per the shareholding pattern, out of the 30 per cent public shareholding, institutional investors held 18.72 per cent stake in Nureca. Individual shareholders held 5.87 per cent holding, while bodies corporate and Yash Shares and Stock Private Limited held 5.30 per cent and 4.41 per cent stake, respectively.
Here are the top stocks that are likely to be in focus today:
Nureca: Shares of Nureca will list on the bourses today. The IPO by home healthcare and wellness products provider that ran between February 15-17 witnessed 40 times subscription.
Max Financial Services, Axis Bank: The Insurance Regulatory and Development Authority of India (IRDAI) has given its approval for the acquisition of up to 12 per cent stake in Max Life Insurance by Axis Bank and its subsidiaries Axis Capital and Axis Securities.
Affle (India): Affle Holdings Pte Ltd, a promoter of Affle (India), on Wednesday, offloaded 3 lakh shares of the company worth over Rs 161 crore through an open market transaction.